rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Andrew E. Singer

Director

Company insider

Files Form 4 as: Director, Kyntra Bio; EVP & CFO, Epizyme.

In numbers

Trades disclosed
106
Buys
0
Sells
17
Bought
$0
Sold
$325K
Companies
2
Companies where not an officer
1
First trade
9 Feb 2015
Last trade
1 Oct 2026
Last filed
6 Oct 2026

Companies traded

Where they are an officer
EpizymeOfficer · last 9 Aug 20170 buys · 17 sells
Everywhere else they filed: board seats, 10% stakes, other companies
KYNB Kyntra BioDirector · Biotechnology · last 1 Oct 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 6 Oct 2026KYNB Kyntra Biooption or derivative · BiotechnologySEC FORM 4 Code A—14,000 at $0.00filing
9 Aug 2017filed 10 Aug 2017EpizymeSEC FORM 4 Code M—1,682filing
9 Aug 2017filed 10 Aug 2017EpizymeSEC FORM 4 Code M—778filing
9 Aug 2017filed 10 Aug 2017Epizymeoption or derivativeSEC FORM 4 Code M—1,682 at $0.00filing
9 Aug 2017filed 10 Aug 2017Epizymeoption or derivativeSEC FORM 4 Code M—778 at $0.00filing
10 Jul 2017filed 12 Jul 2017EpizymeSEC FORM 4 Code M—1,682filing
10 Jul 2017filed 12 Jul 2017EpizymeSEC FORM 4 Code M—777filing
10 Jul 2017filed 12 Jul 2017Epizymeoption or derivativeSEC FORM 4 Code M—1,682 at $0.00filing
10 Jul 2017filed 12 Jul 2017Epizymeoption or derivativeSEC FORM 4 Code M—777 at $0.00filing
30 Jun 2017filed 5 Jul 2017EpizymeSEC FORM 4 Sold$47K3,024 at $15.50filing
9 Jun 2017filed 12 Jun 2017EpizymeSEC FORM 4 Code M—1,682filing
9 Jun 2017filed 12 Jun 2017EpizymeSEC FORM 4 Code M—777filing
9 Jun 2017filed 12 Jun 2017Epizymeoption or derivativeSEC FORM 4 Code M—1,682 at $0.00filing
9 Jun 2017filed 12 Jun 2017Epizymeoption or derivativeSEC FORM 4 Code M—777 at $0.00filing
9 May 2017filed 11 May 2017EpizymeSEC FORM 4 Code M—1,682filing
9 May 2017filed 11 May 2017EpizymeSEC FORM 4 Code M—778filing
9 May 2017filed 11 May 2017Epizymeoption or derivativeSEC FORM 4 Code M—1,682 at $0.00filing
9 May 2017filed 11 May 2017Epizymeoption or derivativeSEC FORM 4 Code M—778 at $0.00filing
10 Apr 2017filed 11 Apr 2017EpizymeSEC FORM 4 Code M—1,682filing
10 Apr 2017filed 11 Apr 2017EpizymeSEC FORM 4 Code M—777filing

News

Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directorsmanilatimes.net · 1 Oct 2026

1 headline in the last 90 days name Andrew E. Singer; no company of theirs resolves to a name we track.

Sectors

Not placed17

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.